Lebrikizumab Is an Effective Treatment for Moderate-To-Severe Atopic Dermatitis in Patients ≥60 Years of Age

AuthID
 P-016-WVE
13
Author(s)
Armstrong, A
·
Zirwas, M
·
Napolitano, M
·
Staumont-Salle, D
·
Atwater, AR
·
Dossenbach, M
·
Agell, H
·
Qiao, MH
·
Pierce, E
·
Piruzeli, MLB
·
Mostaghimi, A
Document Type
Abstract
Year published
2024
Published
in BRITISH JOURNAL OF DERMATOLOGY, ISSN: 0007-0963
Volume: 191
Conference
Revolutionizing Alopecia Areata, Vitiligo and Eczema Conference (Rave), Date: JUN 08-10, 2024, Location: Chicago, IL
Indexing
Wos®
Google Scholar®
Publication Identifiers
Wos: WOS:001285698100022
Source Identifiers
ISSN: 0007-0963
Export Publication Metadata
Marked List
 Add to Marked List
Info
At this moment we don't have any links to full text documens.

A place for researchers and their institutions

Useful Links

Get Help

© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service